© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
A Family Physician on When to Manage Depression in Primary Care—and When to Refer
September 9th 2025
Family physician Teresa Lovins, MD, explains how primary care clinicians can determine when to manage depression and when urgent referral is needed.
How to Talk to Patients About Respiratory Virus Vaccines This Year? The Same Way We Always Do
August 20th 2025
William Schaffner, MD, advises first and foremost to stay away from politics, to acknowledge and normalize patient fear and concern, and to answer quickly and with confidence.
.jpg?fit=crop&auto=format)
Back-to-School Pediatric Vaccination: A Family Physician’s Perspective on Boosting Rates, Countering Misinformation
August 19th 2025
Sarah Sams, MD, emphasizes education, empathy, and proactive communication to support families and protect public health.
Primary Care Needs the Right Tools to Identify MCI Early, Says Rodney Swenson, PhD
August 6th 2025
If primary care clinicians are to meet the cognitive screening demands that are growing with an aging population, they need the sharpest tools in the box, this expert says.
FDA Extends Review Period for Elinzanetant NDA for Menopausal Vasomotor Symptoms
July 25th 2025
The Menopause Society Annual Meeting
Bayer's elinzanetant, a potential nonhormonal treatment for menopausal symptoms, awaits FDA approval after a 90-day review extension.
Novel GLP-1/GLP-2 Agent Reduces Body Weight by Up to 8.3% in Phase 1b Obesity Trial
July 7th 2025
ADA 2025: Dapiglutide showed promising safety and weight loss results in a phase 1b trial, targeting obesity and inflammation with once-weekly dosing.
ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions
June 20th 2025
The ADA unveils the association's first Standards of Care for Overweight and Obesity, with a chapter on weight stigma and bias one of the first released.
2025 ACOG Annual Clinical & Scientific Meeting: What You May Have Missed
June 10th 2025
From primary care management of heavy menstrual bleeding to postpartum depression screening, find out what you may have missed at ACOG 2025.
Ruxolitinib Cream Demonstrates Long-Term Safety and Disease Control in Young Patients With Atopic Dermatitis
June 6th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: In the TRuE-AD3 study, participants aged 2-6 and 7-11 years spent nearly half of the long-term treatment period free of medication.
INTEGUMENT-OLE: Roflumilast Cream Maintains Long-Term Disease Control in Pediatric and Adolescent Atopic Dermatitis
June 6th 2025
Revolutionizing Atopic Dermatitis (RAD)
RAD 2025: Roflumilast cream significantly improved atopic dermatitis in children and adolescents through 52 weeks, offering a safe, effective treatment option.